(Press-News.org) The U.S. Department of Defense awarded just under $514,000 to an interdisciplinary team of researchers at the U of A to study the efficacy of “self-delivering” gene editors in the treatment of Duchenne Muscular Dystrophy, or DMD.
DMD results from a mutation in the dystrophin gene and is one of the most severe inherited muscular dystrophies, leading to deterioration of the muscle fibers. Presently, there is no cure, but advances in treatment have helped patients live longer, better lives.
Gene therapy designed to supply replacement genes to skeletal muscles may hold the key to a cure. Current treatment techniques favor a viral delivery of replacement genes, through what’s known as an adeno associated virus, to targeted skeletal muscles. But there are still many unknowns with this form of treatment, including how long a given gene replacement therapy will last, whether the body will counteract the therapy through a strong immune response and whether the gene therapy will result in unintentional genomic changes, which can trigger undesirable side effects.
The researchers will explore non-viral options for delivering gene therapy to potential DMD patients, specifically “self-delivering” gene editors. They are self-delivering in that they would move through the bloodstream into muscle tissues through a process called endothelial transcytosis, rather than using a viral delivery system.
Initial testing will be done through microphysiological systems known as organs-on-chips that can model the endothelial barrier. Endothelial cells line blood vessels and regulate the movement of materials between blood vessels and surrounding tissues. The researchers will study both skeletal muscles cells and muscle stem cells that are responsible for rebuilding muscle.
They hope to identify the best gene editors in terms of safety and efficacy, ideally allowing a wider pool of patients to access these innovative new gene therapies.
Chris Nelson, an assistant professor of biomedical engineering, will be the principal investigator. Nelson’s lab specializes in developing biologically inspired strategies for controlled drug and gene delivery for gene therapy and regenerative medicine.
Nelson noted that “this project is the result of an exciting collaboration between multiple fields of research.”
This includes Kartik Balachandran, a professor of biomedical engineering, serving as a co-principal investigator. Balachandran specializes in the creation of organs-on-chips — 3D organ constructs engineered from human cells and tissues that mimic critical human functions. Joining them is Kevin Murach, an assistant professor in the Health, Human Performance and Recreation Department, who specializes in the study of skeletal muscle mass regulation, as an additional co-PI.
Nelson noted that Shilpi Agrawal, a postdoctoral researcher in his lab, made important contributions to drafting the award proposal and collecting preliminary data. This is Nelson’s second major grant in recent months, complementing a recent $1.8 million award from the National Institutes of Health.
END
Department of Defense funds study of gene therapy for muscular degeneration
The $514,000 DOD award will be used to study the efficacy of gene editors in the treatment of Duchenne Muscular Dystrophy
2024-10-29
ELSE PRESS RELEASES FROM THIS DATE:
People’s exposure to toxic chemicals declined in the U.S. following listing under California law
2024-10-29
With growing concern about the ubiquity of toxic chemicals in consumer products, many states have passed laws aimed at protecting people from harmful substances in everyday items like cosmetics, cleaning supplies, plastics, and food packaging. California’s Proposition 65, for instance, is considered one of the most extensive toxics laws in the country.
But does the law work? According to a new study published in the journal Environmental Health Perspectives, it does.
“Not only have people’s exposures to specific toxic chemicals gone down in California, ...
Trauma, homelessness afflict gender affirming care patients at higher rates
2024-10-29
A survey of patients receiving gender affirming care shows that commercial insurance pays for most of their treatments, they receive less care in the South than other parts of the U.S. and they deal with disproportionate levels of housing insecurity and trauma compared to others, according to a new study by researchers at the Colorado School of Public Health and the University of Colorado Anschutz Medical Campus.
The study, using data provided by Kythera Labs, a healthcare clearinghouse, examined millions of insurance claims by patients undergoing gender affirming care (GA) and those not. It also looked at social determinants of healthcare (SDOH), non-medical factors ...
New $5 million DoE award supports KU startup’s green hydrogen energy research
2024-10-29
LAWRENCE — With $5 million in support from the U.S. Department of Energy, the University of Kansas and Avium — a startup firm founded by researchers from KU’s School of Engineering — aim to make clean hydrogen more affordable.
According to the DoE, the work at KU is part of $750 million in funding for 52 projects across 24 states “to dramatically reduce the cost of clean hydrogen and reinforce American leadership in the growing hydrogen industry.”
Green hydrogen is a key tool in the worldwide ...
A navigation system for microswimmers
2024-10-29
Microswimmers often need to independently navigate narrow environments like microchannels through porous media or blood vessels. The swimmers can be of biological origin, like algae or bacteria, but also constitute custom designed structures used for the transport of chemicals and drugs. In these cases, it is important to control how they swim in relation to walls and boundaries - as one might want them to exchange fuel or information, but also avoid them to stick where they are not supposed to.
Many swimmers are electrically ...
Study finds early TAVR can be beneficial for patients with asymptomatic severe aortic stenosis
2024-10-29
WASHINGTON, DC – OCTOBER 28, 2024 – The first powered randomized trial examining early intervention with transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe aortic stenosis (AS) found this strategy to be both a safe and effective alternative to clinical surveillance (CS).
Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional ...
Implantable microparticles can deliver two cancer therapies at once
2024-10-29
Patients with late-stage cancer often have to endure multiple rounds of different types of treatment, which can cause unwanted side effects and may not always help.
In hopes of expanding the treatment options for those patients, MIT researchers have designed tiny particles that can be implanted at a tumor site, where they deliver two types of therapy: heat and chemotherapy.
This approach could avoid the side effects that often occur when chemotherapy is given intravenously, and the synergistic effect of the two therapies ...
Early intervention in patients with asymptomatic severe aortic stenosis and myocardial fibrosis falls short of expected benefits
2024-10-29
WASHINGTON, DC – OCTOBER 28, 2024 – The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and mid-wall myocardial fibrosis on magnetic resonance imaging did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned aortic stenosis hospitalization compared with guideline-directed conservative management.
Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular ...
The surprising reason a classical computer beat a quantum computer at its own game
2024-10-29
Earlier this year, researchers at the Flatiron Institute’s Center for Computational Quantum Physics (CCQ) announced that they had successfully used a classical computer and sophisticated mathematical models to thoroughly outperform a quantum computer at a task that some thought only quantum computers could solve.
Now, those researchers have determined why they were able to trounce the quantum computer at its own game. Their answer, presented on October 29 in Physical Review Letters, reveals that the quantum problem they tackled — involving ...
Researchers Aim To Get Leg Up on Bone Repair with 3D-Printed Femur
2024-10-29
University of Texas at Dallas mechanical engineers have designed a 3D-printed femur that could help doctors prepare for surgeries to repair bones and develop treatments for bone tumors.
The engineers, who worked in collaboration with UT Southwestern Medical Center orthopedic surgeons, published their first study on the 3D-printed thigh bone online Aug. 5 in the Journal of Orthopaedic Research.
The study, which focused on the middle section of the bone, establishes 3D-printing parameters for a femur for use in biomechanical testing. Researchers said more studies will be needed before the technology could be available for widespread use.
To study and validate innovative surgical implants ...
Transforming patient care: study finds bedside interdisciplinary rounds boost satisfaction for patients and providers
2024-10-29
A study led by researchers at the University of Colorado Anschutz Medical Campus reveals patients and providers have more positive overall care experiences when the entire healthcare team is a part of bedside interdisciplinary rounds (BIDR).
The study published today in the Journal of General Internal Medicine.
The study found that BIDR, when the team meets at a patients’ bedside in the hospital to discuss care plans, helps build trust between patients and their healthcare providers and within healthcare teams by allowing everyone to observe and work together more closely.
“Traditional ...
LAST 30 PRESS RELEASES:
Metformin changes blood metal levels in humans
Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation
Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease
Participation of women in cardiovascular trials from 2017 to 2023
Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction
Changes in biology of internal fat may be the leading cause of heart failure
Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk
Promising new drug for people with stubborn high blood pressure
One shot of RSV vaccine effective against hospitalization in older adults for two seasons
Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults
Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis
Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine
High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults
Prevalence, determinants, and time trends of cardiovascular health in the WHO African region
New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers
CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients
Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock
Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes
High Mountain Asia’s shrinking glaciers linked to monsoon changes
All DRII-ed up: How do plants recover after drought?
Research on stigma says to just ‘shake it off’
Scientists track lightning “pollution” in real time using NASA satellite
Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy
Hot days make for icy weather, Philippine study finds
Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology
World's first clinical trial showing lubiprostone aids kidney function
Capturing language change through the genes
Public trust in elections increases with clear facts
Thawing permafrost raised carbon dioxide levels after the last ice age
New DNA test reveals plants’ hidden climate role
[Press-News.org] Department of Defense funds study of gene therapy for muscular degenerationThe $514,000 DOD award will be used to study the efficacy of gene editors in the treatment of Duchenne Muscular Dystrophy